3rd Quarter - Termination

GENOMIC HEALTH for GENOMIC HEALTH

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 30, 2014

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2014 $160,000 Replaced
3rd Quarter - Termination (this page) Nov 14, 2014 $160,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reimbursement of Lab Tests, Coverage of Lab Tests, FDA Registration of Lab Tests

LobbyistCovered position, as disclosed
ANDREA BERGMAN —
PAUL RADENSKY —
DANIELLE SCELFO —
SHEILA WALCOFF —
ERIC ZIMMERMAN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.